{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Adam A"],"funding":["Bill and Melinda Gates Foundation"],"pagination":["4030-4039"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11650653"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["10(12)"],"pubmed_abstract":["The coronavirus pandemic outbreak of 2019 highlighted the critical importance of preparedness for current and future public health threats (https://www.mmv.org/mmv-open/global-health-priority-box/about-global-health-priority-box). While the main attention for the past few years has been on COVID-19 research, this focus has reduced global resources on research in other areas, including malaria and neglected tropical diseases (NTDs). Such a shift in focus puts at risk the hard-earned progress in global health achieved over the past two decades (https://www.who.int/news-room/spotlight/10-global-health-issues-to-track-in-2021). To address the urgent need for new drugs to combat drug-resistant malaria, emerging zoonotic diseases, and vector control, Medicines for Malaria Venture (MMV) and Innov"],"journal":["ACS infectious diseases"],"pubmed_title":["Global Health Priority Box─Proactive Pandemic Preparedness."],"pmcid":["PMC11650653"],"funding_grant_id":["INV-007155"],"pubmed_authors":["Norton L","Hawryluk N","Burrows JN","Hooft van Huisjduijnen R","Bryant R","Laleu B","Adam A","Besson D","Willis PA","Samby KK","Canan S","Rees S","Palmer M","Robinson D"],"additional_accession":[]},"is_claimable":false,"name":"Global Health Priority Box─Proactive Pandemic Preparedness.","description":"The coronavirus pandemic outbreak of 2019 highlighted the critical importance of preparedness for current and future public health threats (https://www.mmv.org/mmv-open/global-health-priority-box/about-global-health-priority-box). While the main attention for the past few years has been on COVID-19 research, this focus has reduced global resources on research in other areas, including malaria and neglected tropical diseases (NTDs). Such a shift in focus puts at risk the hard-earned progress in global health achieved over the past two decades (https://www.who.int/news-room/spotlight/10-global-health-issues-to-track-in-2021). To address the urgent need for new drugs to combat drug-resistant malaria, emerging zoonotic diseases, and vector control, Medicines for Malaria Venture (MMV) and Innov","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Dec","modification":"2025-04-04T01:08:57.532Z","creation":"2025-04-04T01:08:57.532Z"},"accession":"S-EPMC11650653","cross_references":{"pubmed":["39488746"],"doi":["10.1021/acsinfecdis.4c00700"]}}